darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet
- RxCUI
- 485423
- RxNorm name
- darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet
- Display name
- darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet
- Full name
- darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Darifenacin | DARIFENACIN | Torrent Pharmaceuticals Limited | e84f1ae3-b9a2-4a15-a299-c75373891cc1 | 2026-02-10 | Warnings, Adverse reactions | 485423 |
| Darifenacin | DARIFENACIN | Bryant Ranch Prepack | 697eba55-9e1f-4036-baed-5644c810f166 | 2025-11-17 | Warnings, Adverse reactions | 485423 |
| Darifenacin | DARIFENACIN HYDROBROMIDE | Cipla USA Inc. | 6e8470d1-c3e6-4644-b70a-aa47ddf79676 | 2025-10-27 | Warnings, Adverse reactions | 485423 |
| Darifenacin | DARIFENACIN | Aurobindo Pharma Limited | 28ed5b58-46dd-4140-a877-4b422f780a94 | 2024-04-19 | Warnings, Adverse reactions | 485423 |
| Darifenacin | DARIFENACIN | Rising Pharma Holdings, Inc. | e2aa9544-0136-463d-a73b-1a299534446a | 2024-04-19 | Warnings, Adverse reactions | 485423 |
| DARIFENACIN | DARIFENACIN | Alembic Pharmaceuticals Limited | da7c2732-232c-4e71-92d9-577ef8617f56 | 2023-01-30 | Warnings, Adverse reactions | 485423 |
| Darifenacin | DARIFENACIN | Macleods Pharmaceuticals Limited | 7ae60119-e22c-4806-a5d8-db7c9e8984a2 | 2023-01-25 | Warnings, Adverse reactions | 485423 |
| Darifenacin | DARIFENACIN HYDROBROMIDE | POLYGEN PHARMACEUTICALS INC. | 62a72d3e-3c33-4f2d-b3d0-2e014f704c63 | 2022-12-01 | Warnings, Adverse reactions | 485423 |
| DARIFENACIN | DARIFENACIN | Alembic Pharmaceuticals Inc. | 9f6952c8-e547-4f3e-a978-a88d6ea9dc10 | 2021-12-13 | Warnings, Adverse reactions | 485423 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 697eba55-9e1f-4036-baed-5644c810f166 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 100 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:2004 | 20251117 |
| e84f1ae3-b9a2-4a15-a299-c75373891cc1 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 10 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:2004 | 20260210 |
| 6e8470d1-c3e6-4644-b70a-aa47ddf79676 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20251027 |
| 9f6952c8-e547-4f3e-a978-a88d6ea9dc10 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20211213 |
| 28ed5b58-46dd-4140-a877-4b422f780a94 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 5 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20240419 |
| d09e16f4-42a9-402f-a37b-2eca55ceafbf | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 5 | These highlights do not include all the information needed to use DARIFENACIN extended-release tablets safely and effectively. See full prescribing information for DARIFENACIN extended-release tablets. DARIFENACIN extended-release tablets Initial U.S. Approval: 2004 | 20200409 |
| 7ae60119-e22c-4806-a5d8-db7c9e8984a2 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 4 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20230125 |
| da7c2732-232c-4e71-92d9-577ef8617f56 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20230130 |
| 62a72d3e-3c33-4f2d-b3d0-2e014f704c63 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20221201 |
| e2aa9544-0136-463d-a73b-1a299534446a | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20240419 |
| 7e9f2cec-8c9f-7668-dfb4-6ab57c9d3e8a | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | 20210430 |
| a293cece-e97a-4e67-be72-b187568e3b11 | darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY] | 3 | 1 | ENABLEX ® (darifenacin) Extended -release tablets Rx only Prescribing Information | 20100101 |